DCGI

DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 Patients
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 PatientsSwarajya StaffJun 12, 2021 08:33 AM
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In IndiaSwarajya StaffJun 3, 2021 07:34 AM
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: Report
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: ReportSwarajya StaffJun 2, 2021 06:31 AM
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas RegulatorsSwarajya StaffJun 2, 2021 05:31 AM
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19Swarajya StaffMay 27, 2021 06:59 AM
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: Report
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: ReportSwarajya StaffMay 14, 2021 09:00 AM
Bharat Biotech's Covaxin Recommended By DCGI's Expert Panel For Phase 2 And 3 Trial On 2 To 18 Years Old: Report
Bharat Biotech's Covaxin Recommended By DCGI's Expert Panel For Phase 2 And 3 Trial On 2 To 18 Years Old: ReportSwarajya StaffMay 12, 2021 03:12 AM
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers 
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers Bhaswati Guha Majumder May 10, 2021 05:28 AM
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 Patients
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 PatientsSwarajya StaffMay 8, 2021 09:46 AM
Patanjali's Coronil Sees Sharp Increase In Demand Even As Questions Persist Over Efficacy Of Kit To Cure Covid-19 Patients
Patanjali's Coronil Sees Sharp Increase In Demand Even As Questions Persist Over Efficacy Of Kit To Cure Covid-19 PatientsBhaswati Guha Majumder May 4, 2021 11:32 AM
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In IndiaSwarajya StaffApr 30, 2021 04:54 AM
Zydus Cadila Begins Advance Production Of Its COVID Vaccine Candidate; To Seek Emergency Use Approval In May Or June: Report
Zydus Cadila Begins Advance Production Of Its COVID Vaccine Candidate; To Seek Emergency Use Approval In May Or June: ReportSwarajya StaffApr 24, 2021 08:25 AM
Zydus Cadila's 'Virafin' Gets Emergency Use Approval From DCGI For Treating Moderate Covid-19 Infections
Zydus Cadila's 'Virafin' Gets Emergency Use Approval From DCGI For Treating Moderate Covid-19 InfectionsSwarajya StaffApr 24, 2021 04:40 AM
J&J Seeks Indian Drug Regulator's Nod For Phase 3 Trials Of Its Single-Dose COVID-19 Vaccine, Import License: Report
J&J Seeks Indian Drug Regulator's Nod For Phase 3 Trials Of Its Single-Dose COVID-19 Vaccine, Import License: ReportSwarajya StaffApr 20, 2021 03:01 AM
Centre Takes Steps To Increase Antiviral Remdesivir Production From 38 Lakh Vials Per Month To 78 Lakh Vials Per Month
Centre Takes Steps To Increase Antiviral Remdesivir Production From 38 Lakh Vials Per Month To 78 Lakh Vials Per MonthSwarajya StaffApr 15, 2021 06:36 AM
India To Produce 850 Million Doses Of Sputnik V Covid-19 Vaccine Annually: RDIF
India To Produce 850 Million Doses Of Sputnik V Covid-19 Vaccine Annually: RDIF IANSApr 14, 2021 02:51 AM
Timeline Of Russian Sputnik V Covid-19 Vaccine, Approved For Emergency Use In India
Timeline Of Russian Sputnik V Covid-19 Vaccine, Approved For Emergency Use In IndiaBhaswati Guha MajumderApr 13, 2021 03:55 PM
India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's Recommendation
India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's RecommendationSwarajya StaffApr 13, 2021 02:36 AM
Pune-Based Gennova Set To Begin Clinical Trials Of India's First mRNA Covid-19 Vaccine This Month
Pune-Based Gennova Set To Begin Clinical Trials Of India's First mRNA Covid-19 Vaccine This MonthSwarajya StaffApr 10, 2021 05:23 AM
With Phase 3 Trials Almost Complete, Dr Reddy's Seeks DCGI Nod For Emergency Use Of Russian Sputnik V Covid Vaccine
With Phase 3 Trials Almost Complete, Dr Reddy's Seeks DCGI Nod For Emergency Use Of Russian Sputnik V Covid Vaccine Swarajya StaffFeb 20, 2021 06:14 AM
Load More